Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications cardiomyopathies: therapeutics based on molecular phenotype.
The enduring subdivision of cardiomyopathies into hypertrophic (HCM), dilated (DCM), and restrictive (RCM) categories reflects the emphasis of traditional classifications on morphology. Rapid advances in the genetic interrogation of these disorders have redefined their taxonomy and revealed potentia...
Main Authors: | Ashrafian, H, Watkins, H |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy.
by: Ashrafian, H, et al.
Published: (2011) -
Ferroptosis in Cardiovascular Disease and Cardiomyopathies: Therapeutic Implications of Glutathione and Iron Chelating Agents
by: John Dawi, et al.
Published: (2024-03-01) -
Implications of the gut microbiome in cardiovascular diseases: Association of gut microbiome with cardiovascular diseases, therapeutic interventions and multi-omics approach for precision medicine
by: Prabhakar Singh, et al.
Published: (2024-03-01) -
Molecular Pathways in Prolactinomas: Translational and Therapeutic Implications
by: Betina Biagetti, et al.
Published: (2021-10-01) -
RNA modification in cardiovascular disease: implications for therapeutic interventions
by: Cong Wang, et al.
Published: (2023-10-01)